Decreased serum endogenous secretory receptor for advanced glycation endproducts and increased cleaved receptor for advanced glycation endproducts levels in patients with atrial fibrillation

International Journal of Cardiology

Volumn 158, Issue 3, 2012, Pages 471-472

  Zhao, Dongdong ^a   Wang, Yong ^a   Xu, Yawei ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Atrial fibrillation; cRAGE; esRAGE; HMGB1; Inflammation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN;

ADULT; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT ATRIUM DIAMETER; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 84863613842     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.042     Document Type: Article

References (13)

1. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
2. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study JAMA 285 2001 2370 2375
3. T. Liu, G. Li, L. Li, and P. Korantzopoulos Association between C-reaction protein and recurrence of atrial fibrillation after successful electrical cardioversion J Am Coll Cardiol 49 2007 1642 1648
4. D.I. Leftheriotis, K.T. Fountoulaki, and P.G. Flevari The predictive value of iinflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation Int J Cardiol 135 2009 361 369
5. J. Li, J. Solus, and Q. Chen Role of inflammation and oxidative stress in atrial fibrillation Heart Rhythm 7 2010 438 444
6. M. Andrassy, H.C. Volz, and J.C. Igwe High-mobility group box-1 in ischemia-reperfusion injury of the heart Circulation 117 2008 3216 3226
7. X.X. Yan, L. Lu, and W.H. Peng Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients Atherosclerosis 205 2009 544 548
8. X. Hu, W. Zhou, and Q. Bai Increased serum high mobility group box 1 protein in patients with atrial fibrillation Biomed Aging Pathol 1 2011 52 55
9. E. Watanabe, T. Arakawa, and T. Uchiyama High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion Int J Cardiol 108 2006 346 353
10. G. Basta Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications Atherosclerosis 196 2008 9 21
11. L.J. Wang, L. Lu, and F.R. Zhang Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure Eur J Heart Fail 13 2011 440 449
12. L.J. Sparvero, D. Asafu-Adjei, and R. Kang RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation J Transl Med 7 2009 17
13. A. Raucci, S. Cugusi, and A. Antonelli A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10) FASEB J 22 2008 3716 3727